Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient

Pediatric Transplantation

Volumn 9, Issue 6, 2005, Pages 792-796

  Quirós Tejeira, Rubén E ^a,b,c   Chang, I Fen ^b   Bristow, Lisa J ^a   Karpen, Saul J ^a   Goss, John A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Childrens Cancer Center   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Immunosuppression; Liver transplantation; Pediatrics; Phenobarbital and cytochrome p450; Tacrolimus toxicity

Indexed keywords

CYTOCHROME P450 3A4; PHENOBARBITAL; TACROLIMUS;

ARTICLE; CASE REPORT; CHRONIC DRUG ADMINISTRATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG OVERDOSE; GRAFT REJECTION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFECTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PEDIATRIC SURGERY; PRESCHOOL CHILD;

BILIARY ATRESIA; HALF-LIFE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; PHENOBARBITAL; TACROLIMUS;

EID: 27944489248     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00368.x     Document Type: Article

References (23)

1. PETERS DH, FITTON A, PLOSKER GL, FAULDS D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993: 46: 746-794.
2. SAWADA SS, KAWASE YT. Novel immunosuppressive agent. FK506. In vitro effects on the cloned T-cell activation. J Immunol 1987: 139: 1797-1803
3. MORRIS RE, WU J, SHORTHOUSE R. Comparative immunopharmacologic effects of FK 506 and CyA in vitro models of organ transplantation. Transplant Proc 1990: 22: 110-112.
4. MORGAN ET, LI-MASTERS T, CHENG PY. Mechanisms of cytochrome p450 regulations by inflammatory factors. Toxicology 2002: 181-182: 207-210.
5. RENTON KW. Alterations of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 2001: 92: 147-163.
6. HOLLAND KD. Efficacy, pharmacology and adverse effects of antiepileptic drugs. Neurol Clin 2001: 19: 313-345.
7. CURRAN CF, BLAHUNK PC, LAWRENCE ID. Acute overdoses of tacrolimus. Transplantation 1996: 62: 1376-1377.
8. YEH CN, HSIEH CH, HUNG CM, JENG LB, CHAO TC, CHEN MF. Acute overdoses of tacrolimus (FK 501). Dig Dis Sci 1999: 44: 1650-1652.
9. MRVOS R, HODGEMAN M, KREZELOK EP. Tacrolimus (FK 506) overdose: a report of five cases. Clin Toxicol 1997: 35: 395-399
10. VENTAKATARAMANAN R, JAIN A, CADOFF E, et al. Pharmacokinetics of FK506: preclinical and clinical studies. Transpl Proc 1991: 23: 2736-2740
11. PRZEPIORKA D, SUZUKI J, IPPOLITI C, HESTER JP, FRITSCHE HA. Blood tacrolimus concentration unchanged by plasmapheresis. Am J Hosp Pharm 1994: 51: 1993.
12. VENKATARAMANAN R, JAIN A, WARTY VS, et al. Pharmacokinetics of FK506 in transplant recipients. Transpl Proc 1991: 23: 2736-2740.
13. ABU-ELMAGD K, FUNG JJ, ALESSAINI M, et al. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 1991: 52: 71-77.
14. IWASAKI K, SHIGARA T, MATSUDA H, et al. Further metabolism of FK506 (tacrolimus): identification and biological activities of the metabolites oxidized at multiple sites of FK506. Drug Metab Dispos 1995: 23: 28-34.
15. SATTLER M, GUENGERICH FP, YUN CH, CHRISTIANS U, SEWING KF. Cytochrome p-450 enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992: 20: 753-761.
16. GOODWIN B, REDINBO MR, KLEIWER SA. Regulation of cyp3a gene transciption by the pregnane X receptor. Annu Rev Pharmacol Toxicol 2002: 42: 1-23.
17. GABRIELSEN J, BENDTSEN A, ERIKSEN H, ANDERSEN S. Methylprenisolone half-life during simultaneous barbiturate treatment and mechanical hyperventilation of neurosurgical patients. J Neurosurg 1985: 62: 182-185.
18. SILLS GJ, SANTANGELI S, FORREST G, BRODIE MJ. Influence of cytochrome P450 induction of the pharmacokinetic and pharmacodynamics of remacemide hydrochloride. Epilepsy Res 2002: 49: 247-254.
19. MCLAUGHLIN GE, ROSSIQUE-GONZALES M, GELMAN B, KATO T. Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. Transpl Proc 2000: 32: 665-668.
20. KARASU Z, GURAKAR A, CARLSON J, et al. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. J Okla State Med Assoc 2001: 94: 121-123.
21. HENRY ML. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles. Clin Transpl 1999: 13: 209-220.
22. SCHEEL AK, BLASCHKE S, SCHETTLER V, et al. Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports. Transpl Proc 2001: 33: 3693-3694.
23. MUELLER AR, PLATZ KP, BECHSTEIN WO, et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994: 58: 155-170.